DR ROBERT BAYLIS AND ASSOCIATES LIMITEDActive

Company number 08549811Private limited companyIncorporated 2013

Key figures

£188,737+2.1%
Net assets 2024/25
+7.2%
Average annual growth 2019/20–2024/25
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, DR ROBERT BAYLIS AND ASSOCIATES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand348,373307,528246,193208,882217,619
Total assets412,856408,193327,506298,175307,920
Total liabilities231,703212,782121,627116,816121,788
Net assets / total equity188,048201,983210,510184,833188,737
Average number of employees21111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DR ROBERT BAYLIS AND ASSOCIATES LIMITED

Company

DR ROBERT BAYLIS AND ASSOCIATES LIMITED is a private limited company registered with Companies House under company number 08549811. It was incorporated on 30 May 2013. Its status is active. The registered office is in Waterlooville (PO7). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 May 2025); the company files small company accounts (filleted). Net assets were £188,737, up 2.1% on the previous year. Cash at bank and in hand was £217,619. Total assets were £307,920 and total liabilities £121,788. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 28 Feb 2027. The next confirmation statement is due by 7 Jun 2027.